MicroRNAs (miRNAs) are noncoding RNAs that posttranscriptionally suppress gene expression through sequence-specific interaction with the 3′ untranslated region (3′UTR) of target mRNAs. By modulating gene networks, miRNAs have been shown to regulate many aspects of cellular homeostasis and physiology, including differentiation, growth, proliferation, and apoptosis. The discovery of extracellular miRNA in blood and other body fluids has prompted investigation into their ability to serve as biomarkers for human disease. Further, many miRNAs have been implicated in the underlying pathophysiology of human disease, and there is substantial opportunity to develop novel molecular therapeutics through manipulation of these miRNAs. Here, we review the evidence for the use of miRNAs as diagnostic and therapeutic targets in human disease. We also describe the advantages and limitations for current miRNA profiling strategies.
|Original language||English (US)|
|Title of host publication||RNA Technologies|
|Publisher||Springer Science and Business Media Deutschland GmbH|
|Number of pages||17|
|State||Published - 2015|
Bibliographical noteFunding Information:
Acknowledgments This work was supported by a VA Merit Award (I01 BX000704 to CDS) and the National Heart Lung and Blood Institute of the National Institutes of Health as a Program of Excellence in Nanotechnology (HHSN268201000043C to GB) and a NHLBI R01 Award (HL 109559 to CDS).
© 2015, Springer International Publishing Switzerland.
- Molecular beacons
- Next-generation sequencing